CBD Protected Rat Brains From Liver Disease-Induced Damage
CBD treatment reduced brain inflammation, oxidative stress, and cognitive impairment in a rat model of hepatic encephalopathy caused by liver damage.
Quick Facts
What This Study Found
CBD (20 mg/kg for 7 days) significantly reduced oxidative stress and inflammation in rats with liver damage-induced brain dysfunction. The treatment modulated NF-kB, ASK1, and JNK inflammatory pathways, improved NAD and serotonin levels, and enhanced cognitive performance on the Morris water maze.
Key Numbers
CBD at 20 mg/kg for 7 days. Reduced NF-kB, ASK1, and JNK signaling. Improved NAD and serotonin levels. Enhanced Morris water maze performance. Improved brain and liver histology.
How They Did This
Controlled rat study using thioacetamide-induced hepatic encephalopathy, with CBD and/or low-dose radiation treatment, measuring oxidative stress, inflammation, neurobehavior, and histopathology.
Why This Research Matters
Hepatic encephalopathy affects up to 40% of cirrhosis patients and has limited treatment options. CBD's neuroprotective effects in this model suggest a potential new therapeutic avenue.
The Bigger Picture
CBD's anti-inflammatory and neuroprotective properties have been demonstrated in multiple brain injury models. Hepatic encephalopathy is a compelling clinical target because current treatments are limited to addressing the liver disease itself.
What This Study Doesn't Tell Us
Rat model may not fully replicate human hepatic encephalopathy. Short 7-day treatment period. Combination with radiation limits ability to isolate CBD effects. Single dose tested.
Questions This Raises
- ?Would CBD work in human hepatic encephalopathy?
- ?What is the optimal dose and duration?
- ?Could CBD complement existing treatments like lactulose and rifaximin?
Trust & Context
- Key Stat:
- CBD reduced brain inflammation and improved cognition in liver disease-induced brain damage
- Evidence Grade:
- Well-designed animal study with multiple molecular and behavioral outcomes, but significant translational gap to human hepatic encephalopathy.
- Study Age:
- 2025 animal study exploring CBD neuroprotection in hepatic encephalopathy.
- Original Title:
- Cannabidiol and low-dose γ-radiation regulate alterations consequences of hepatic-encephalopathy induced by thioacetamide: neuroprotective and anti-inflammatory role.
- Published In:
- Immunopharmacology and immunotoxicology, 47(5), 631-644 (2025)
- Authors:
- Mostafa, Dalia M, Hassan, Asmaa A, Aboghadeer, Ahmad R, Mansour, Somaya Z, Abdel-Hamid, Gehan R
- Database ID:
- RTHC-07194
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help with brain problems caused by liver disease?
In this rat study, CBD reduced brain inflammation and improved memory in a model of hepatic encephalopathy. The effects worked through multiple anti-inflammatory pathways. Human studies are needed to confirm these findings.
How does liver disease affect the brain?
When the liver fails to clear toxins, they accumulate and cause brain inflammation, oxidative stress, and cognitive impairment, a condition called hepatic encephalopathy. CBD appeared to counteract several of these processes in this animal model.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07194APA
Mostafa, Dalia M; Hassan, Asmaa A; Aboghadeer, Ahmad R; Mansour, Somaya Z; Abdel-Hamid, Gehan R. (2025). Cannabidiol and low-dose γ-radiation regulate alterations consequences of hepatic-encephalopathy induced by thioacetamide: neuroprotective and anti-inflammatory role.. Immunopharmacology and immunotoxicology, 47(5), 631-644. https://doi.org/10.1080/08923973.2025.2542131
MLA
Mostafa, Dalia M, et al. "Cannabidiol and low-dose γ-radiation regulate alterations consequences of hepatic-encephalopathy induced by thioacetamide: neuroprotective and anti-inflammatory role.." Immunopharmacology and immunotoxicology, 2025. https://doi.org/10.1080/08923973.2025.2542131
RethinkTHC
RethinkTHC Research Database. "Cannabidiol and low-dose γ-radiation regulate alterations co..." RTHC-07194. Retrieved from https://rethinkthc.com/research/mostafa-2025-cannabidiol-and-lowdose-radiation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.